Novadaq buys fluoro endoscopy technology:
This article was originally published in Clinica
Executive Summary
Toronto-based developer of real-time medical imaging systems Novadaq Technologies is to acquire certain business assets, including a portfolio of fluorescence endoscopy patents, from fellow Canadian medical device company Xillix Technologies. Under the terms of the agreement, Novadaq will pay Xillix Can$3m ($2.7m) on closing, in exchange for the latter's auto-fluorescence and multi-modal imaging portfolio of 31 issued patents and multiple pending patents in the US, Japan and Europe. The purchase also includes the rights to Xillix's pipeline fluorescence imaging technologies. The transaction is slated to close in early May.